| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |